| scholarly article | Q13442814 |
| P2093 | author name string | Martina Müller | |
| Claus Hellerbrand | |||
| Andreas Koch | |||
| Philipp Wiggermann | |||
| Sebastian Buschauer | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| Hepatocellular carcinoma: Where are we? | Q26765182 | ||
| Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma | Q28265788 | ||
| Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 | ||
| Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation. | Q33872467 | ||
| The role of hypoxia inducible factor-1 in hepatocellular carcinoma | Q33914603 | ||
| Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes | Q34177232 | ||
| P-glycoprotein: from genomics to mechanism. | Q34272173 | ||
| Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. | Q34320295 | ||
| Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma | Q34622198 | ||
| Doxorubicin pathways: pharmacodynamics and adverse effects | Q35048393 | ||
| Focus on hepatocellular carcinoma. | Q35721877 | ||
| Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma | Q36625697 | ||
| Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells | Q37362894 | ||
| Epithelial-mesenchymal transition in hepatocellular carcinoma. | Q37620382 | ||
| Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? | Q37760182 | ||
| Treatment of hepatocellular carcinoma: a systematic review | Q38155508 | ||
| Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cells | Q38329458 | ||
| Sensitization of Hep3B hepatoma cells to cisplatin and doxorubicin by corilagin | Q39115585 | ||
| NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cells. | Q39316992 | ||
| Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells. | Q39562856 | ||
| Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression. | Q39580903 | ||
| Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells | Q39613345 | ||
| Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor | Q39680301 | ||
| Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines | Q39817753 | ||
| Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines | Q39821685 | ||
| Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin | Q39909012 | ||
| The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance | Q40133823 | ||
| Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA. | Q40845344 | ||
| Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells | Q43204446 | ||
| Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization | Q43579527 | ||
| Modulation of doxorubicin sensitivity by cyclosporine A in hepatocellular carcinoma cells and their doxorubicin-resistant sublines | Q43608675 | ||
| Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns | Q43670704 | ||
| Transarterial chemoembolization - status quo in Germany | Q45309143 | ||
| MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. | Q54205670 | ||
| Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product P-glycoprotein in primary liver carcinoma. | Q54216784 | ||
| Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma. | Q54337602 | ||
| Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro. | Q54343338 | ||
| Drug-eluting Beads for Liver Embolization: Concentration of Doxorubicin in Tissue and in Beads in a Pig Model | Q61913740 | ||
| Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants | Q84441118 | ||
| [Treatment of hepatocellular carcinoma] | Q85760734 | ||
| P433 | issue | 4 | |
| P921 | main subject | doxorubicin | Q18936 |
| P304 | page(s) | 4635-4640 | |
| P577 | publication date | 2018-01-26 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro. | |
| P478 | volume | 15 |
| Q92081825 | Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile |
| Q97543793 | Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis |
| Q93198729 | Self-enforcing HMGB1/NF-κB/HIF-1α Feedback Loop Promotes Cisplatin Resistance in Hepatocellular Carcinoma Cells |
Search more.